Altered adaptive immune responses in patients with active RA disease mediated by autoantibody-producing B cells (1–3), Th1 and Th17 CD4+ T cells (4, 5), and activated cytotoxic CD8+ T cells (6) have been well characterized. The gene discussed is CD8A; the disease is rheumatoid arthritis.